DongKook Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
DongKook Pharmaceutical has a total shareholder equity of ₩657.6B and total debt of ₩66.2B, which brings its debt-to-equity ratio to 10.1%. Its total assets and total liabilities are ₩921.3B and ₩263.7B respectively. DongKook Pharmaceutical's EBIT is ₩82.9B making its interest coverage ratio -75.2. It has cash and short-term investments of ₩89.6B.
Key information
10.1%
Debt to equity ratio
₩66.24b
Debt
| Interest coverage ratio | -75.2x |
| Cash | ₩89.61b |
| Equity | ₩657.59b |
| Total liabilities | ₩263.66b |
| Total assets | ₩921.25b |
Recent financial health updates
These 4 Measures Indicate That DongKook Pharmaceutical (KOSDAQ:086450) Is Using Debt Reasonably Well
May 29
We Think DongKook Pharmaceutical (KOSDAQ:086450) Can Stay On Top Of Its Debt
May 06DongKook Pharmaceutical (KOSDAQ:086450) Seems To Use Debt Quite Sensibly
Feb 01Recent updates
DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Investors Are Less Pessimistic Than Expected
Aug 07These 4 Measures Indicate That DongKook Pharmaceutical (KOSDAQ:086450) Is Using Debt Reasonably Well
May 29We Think DongKook Pharmaceutical (KOSDAQ:086450) Can Stay On Top Of Its Debt
May 06DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Vies For A Place In Your Dividend Portfolio: Here's Why
Apr 06How Much Of DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Do Insiders Own?
Mar 15The DongKook Pharmaceutical (KOSDAQ:086450) Share Price Has Gained 136%, So Why Not Pay It Some Attention?
Feb 28DongKook Pharmaceutical Co., Ltd.'s (KOSDAQ:086450) Stock Is Going Strong: Is the Market Following Fundamentals?
Feb 14
DongKook Pharmaceutical (KOSDAQ:086450) Seems To Use Debt Quite Sensibly
Feb 01DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Shares Could Be 47% Below Their Intrinsic Value Estimate
Jan 19The Attractive Combination That Could Earn DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) A Place In Your Dividend Portfolio
Jan 06DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Looks Like A Good Stock, And It's Going Ex-Dividend Soon
Dec 24With EPS Growth And More, DongKook Pharmaceutical (KOSDAQ:086450) Is Interesting
Dec 21What Kind Of Investors Own Most Of DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450)?
Dec 08The DongKook Pharmaceutical (KOSDAQ:086450) Share Price Is Up 177% And Shareholders Are Boasting About It
Nov 23Financial Position Analysis
Short Term Liabilities: A086450's short term assets (₩481.2B) exceed its short term liabilities (₩225.4B).
Long Term Liabilities: A086450's short term assets (₩481.2B) exceed its long term liabilities (₩38.2B).
Debt to Equity History and Analysis
Debt Level: A086450 has more cash than its total debt.
Reducing Debt: A086450's debt to equity ratio has reduced from 18.5% to 10.1% over the past 5 years.
Debt Coverage: A086450's debt is well covered by operating cash flow (86.2%).
Interest Coverage: A086450 earns more interest than it pays, so coverage of interest payments is not a concern.